Investor directory

CPP Investments

CPP Investments is a professional investment management organization based in Toronto, Canada, established in 1997 to manage the assets of the Canada Pension Plan. Its primary mandate is to invest these assets in a manner that prioritizes the best interests of Canadian contributors and beneficiaries while seeking to maximize investment returns without exposing the fund to undue risk. The organization was created in response to demographic challenges that threatened the sustainability of the Canada Pension Plan, as fewer workers were supporting a growing number of retirees. CPP Investments diversifies its portfolio across various asset classes, including public equity, private equity, real estate, and infrastructure, to ensure long-term growth and stability for the pension fund.
https://www.cppinvestments.com/
https://crunchbase.com/organization/cpp-investments
https://linkedin.com/company/23230
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=2334713
https://www.privateequityinternational.com/database/#/profile?id=87

Tania Sztamfater Chocolat

Managing Director and Head of São Paulo Office, Head of Active Equities Latin America

Conor Clifford

Principal

Andrew Edgell

Senior Managing Director and Global Head of Credit Investments

Bruce Hogg

Senior Principal at CPP Investment Board

Derek Jackson

Managing Director

Manroop Jhooty

Senior Managing Director and Head of Total Fund Management

Pascal Keutgens

Managing Director, Direct Private Equity

Hafiz Lalani

Managing Director

Scott Lawrence

Managing Director, Head of Infrastructure

Arielle Lynn

Associate, Growth Equity

Paul McCracken Ph.D

Managing Director, Growth Equity

Deborah Orida

Head of Asia Private Equity

Bill Rogers

Managing Director and Global Head of Sustainable Energies

Paul Sinibaldi

Managing Director and Head of Technology Infrastructure

Dushy Sivanithy

Senior Principal - Funds, Managing Director and Head of Secondaries

Geoffrey Souter

Managing Director and Head of Real Assets Credit

Heather Tobin

Senior Managing Director and Global Head of Capital Markets and Factor Investing

Judy Wade

Managing Director and Head of Strategy Execution and Relationship Management

Jonathan Webster Ph.D

COO and Senior Managing Director

Kristopher Weiner

Head of New York Office, Managing Director and Global Leadership Team

Sam Blaichman

Managing Director and Head of Direct Private Equity

Ben Mason

Managing Director and Head of European Credit

Past deals in North Dakota

Allete

Acquisition in 2024
ALLETE, Inc. is an energy company based in Duluth, Minnesota, incorporated in 1906. It operates through two primary segments: Regulated Operations and ALLETE Clean Energy. The Regulated Operations segment includes Minnesota Power and Superior Water, Light and Power Company, which provide electric, natural gas, and water services to a significant number of customers in northeastern Minnesota and northwestern Wisconsin. Additionally, this segment encompasses an investment in American Transmission Company, a utility that maintains electric transmission infrastructure across parts of Wisconsin, Michigan, Minnesota, and Illinois. ALLETE Clean Energy focuses on the development, acquisition, and operation of clean and renewable energy projects, operating around 660 megawatts of wind energy generation. The company is also involved in coal mining operations in North Dakota and real estate investments in Florida, while owning and operating multiple substations with substantial capacity.

Aldevron

Private Equity Round in 2019
Aldevron, LLC is a contract science organization based in Fargo, North Dakota, that specializes in the production of biological products, including plasmid DNA, proteins, antibodies, and nucleic acids. Founded in 1998, the company serves academic and research institutions, as well as pharmaceutical and biotechnology companies, by offering a range of services such as plasmid DNA production, protein production, antibody discovery, and mRNA production. Aldevron focuses on custom manufacturing and provides products for various applications, including gene therapy, gene editing, and diagnostics. Its offerings include DNA vaccine plasmids, reporter plasmids, retroviral vectors, and competent cell production, among others. The company also engages in GMP manufacturing and provides storage, distribution, and stability services, as well as gene synthesis and antibody processing. Aldevron operates both in the United States and Europe, facilitating vital discoveries in the life sciences sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.